Carl Zeiss Meditec AG
Global website (English)
back
Carl Zeiss Meditec AG
recommended searches
popular searches

Financial Publications

New products are the key to our company's success. This innovative strength is the driving force of our growth. In this section we present facts and figures on the company's financial position.

The Management Board

  • Third-party Content Blocked

    The video player is blocked due to your cookie preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Downloads

Key Financial Figures

2023/24
2022/23
2021/22

€m

%

€m

%

€m

%

Revenue

2.066,1

100

2.089,3

100  

1.902,8

100

Research and development expenses

343,1

16,6

349,3

16,7 

291.4

15,3

EBIT

194,5
 

9,4

348,1 

16,7

396,9

20,9

Consolidated profit1

180,2

8,7

292,0

14,0

295,9

15,6

Earnings per share2
(in €)

2,01

3,25

3,29

Dividend per share
(in €)

0,60³

1,103

1,103

Cash flows from operating activities
  

247,3

250,9

188,2

Cash flows from investing activities
  

-412,3

-111,0

-92,9

Cash flows from financing activities

176,2

-135,1

-94,2

Total assets
  

3.393,2

100

3.032,9

100  

2.822,8

 

100

Property, plant and equipment

353,8
 

10,4

315,8

10,4

236,1

8,4

Equity

2.056,5

60,6

2.172,9

71,6

2.030,1

71,9

Net cash4

72,9

2,1

863,9

28,5

885,6

31,4

Employees (number)

5.730

4.832

4.224
  • 1

    Before non-controlling interests
  • 2

    Profit/loss per share attributable to the shareholders of the parent company in the fiscal year
  • 3

    Amount of dividend for proposed by the Supervisory Board and the Management Board of Carl Zeiss Meditec AG
  • 4

    Cash and cash equivalents plus treasury receivables from/payables to the treasury of Carl Zeiss AG